Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

8.06
+0.06000.75%
Post-market: 8.150.0873+1.08%19:56 EDT
Volume:1.12M
Turnover:9.04M
Market Cap:2.53B
PE:-191.45
High:8.14
Open:8.00
Low:7.97
Close:8.00
Loading ...

Amneal Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Generic Drugmaker Amneal Clocks Mixed Q4 Earnings, Plans Expansion In High-Growth Areas Like Weight Loss Products, Biosimilars

Benzinga
·
28 Feb

BUZZ-Amneal Pharma rises on strong 2025 revenue forecast, Q4 revenue beat

Reuters
·
28 Feb

Amneal Pharmaceuticals Q4 Adjusted Earnings Fall, Revenue Rises; 2025 Guidance Set

MT Newswires Live
·
28 Feb

GUIDANCE: (AMRX) Amneal Pharmaceuticals Expects Full Year 2025 Net Revenue Range $3B - $3.1B, vs. FactSet Est of $2.92B

MT Newswires Live
·
28 Feb

Amneal Expects 2025 Revenues Of $3B-$3.1B And Adjusted EPS Of $0.65-$0.70 Versus Consensus Of $2.896B And $0.71, Respectively

Benzinga
·
28 Feb

Amneal Pharmaceuticals Q4 2024 Adj EPS $0.12 Misses $0.15 Estimate, Sales $730.52M Beat $707.55M Estimate

Benzinga
·
28 Feb

Analysts Are Bullish on Top Healthcare Stocks: Amneal Pharmaceuticals (AMRX), Revolution Medicines (RVMD)

TIPRANKS
·
27 Feb

Why this newly public biotech could become a force in obesity treatments

Dow Jones
·
26 Feb

Amneal (AMRX) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks
·
25 Feb

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
25 Feb

Amneal Pharmaceuticals' Shares Rise After JPMorgan Upgrade

MT Newswires Live
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Reuters
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Reuters
·
24 Feb

JPMorgan Upgrades Amneal Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $12 From $9

MT Newswires Live
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Nike, Domino's Pizza, Apple

Reuters
·
24 Feb

Amneal Pharmaceuticals Raised to Overweight From Neutral by JP Morgan

Dow Jones
·
24 Feb

BUZZ-Amneal Pharma rises; J.P.Morgan upgrades stock, raises PT

Reuters
·
24 Feb

U.S. RESEARCH ROUNDUP-Amneal pharma, Aramark, Bluebird Bio

Reuters
·
24 Feb

BRIEF-Amneal Launches Mesalamine And Receives U.S. FDA Approval For Lenalidomide

Reuters
·
19 Feb